Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2022/1/14 申報
- 申報編號
- 0001209191-22-003402
- 申報時間
- 2022/1/14
- 交易日
- 2021/12/28-2022/1/14
- 申報延遲
- 17 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $469.4 萬。交易後 17 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/13 | Class A Common Stock | C轉換取得 | +87,000 | $0.00 | $0 | 110,470 | 直接 | |
| 2022/1/13 | Class A Common Stock | S賣出處分 | −78,206 | $14.26F3 | −$1,115,217.56 | 32,264 | 直接 | |
| 2022/1/13 | Class A Common Stock | S賣出處分 | −8,794 | $14.96F4 | −$131,558.24 | 23,470 | 直接 | |
| 2022/1/14 | Class A Common Stock | C轉換取得 | +254,000 | $0.00 | $0 | 277,470 | 直接 | |
| 2022/1/14 | Class A Common Stock | S賣出處分 | −254,000 | $13.57F5 | −$3,446,780 | 23,470 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/28 | Class A Common Stock | G贈與處分 | −75,000 | $0.00 | $0 | 8,119,342 | 直接 | |
| 2022/1/13 | Class A Common Stock | C轉換處分 | −87,000 | $0.00 | $0 | 8,032,342 | 直接 | |
| 2022/1/14 | Class A Common Stock | C轉換處分 | −254,000 | $0.00 | $0 | 7,778,342 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
This transaction was executed in multiple trades at prices ranging from $13.80 to $14.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $14.80 to $15.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $13.09 to $14.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。